Monopar Therapeutics
MNPR
$0.61
Share price
0.18%
Change (1 day)
-29.64%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) - Total assets
Total assets on the balance sheet as of December 2023 : $7.34 M
According to Monopar Therapeutics's latest financial reports the company's total assets are $7.34 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Monopar Therapeutics - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $13.22 M | -35.55% |
| 2021-12-31 | $20.52 M | 21.66% |
| 2020-12-31 | $16.86 M | 26.34% |
| 2019-12-31 | $13.35 M | 82.46% |
| 2018-12-31 | $7.31 M | -26.31% |
| 2017-12-31 | $9.93 M | 242.98% |
| 2016-12-31 | $2.89 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | 3,330.93% | 🇺🇸 USA |